What we found is that when we compare patients that receive GLP-1 receptor agonists within a year of their cirrhosis diagnosis, compared to those patients that undergo metabolic bariatric surgery within the first year of their diagnosis, the GLP-1 patients are having less ascites over the 10-year follow-up period, less hepatorenal syndrome, less hepatic encephalopathy, and less varices as well
HUBERMAN: So when people are combining different things in cocktail, it's not necessarily a bad thing, but you want to make sure that you're working with someone who's very familiar with peptides
Semaglutide only helps control your appetite it does not burn fat or actively make you lose weight on its own
Like any long-term medication, its important to use Wegovy under medical supervision to minimise risks and ensure it remains effective
Lu P, Yan J, Liu K, Garbacz WG, Wang P, Xu M, et al